Comprehensive analysis of subtype-specific outcomes and management in castleman disease: A 20-year cohort Study
Authors
Discussion
Loading...
Member takes
Implication
Retrospective analysis reveals treatment responses and outcomes in castleman disease subtypes, highlighting the role of human herpesvirus 8.
Key Points
- Overall survival at 5 years was 99% for unicentric, 97.7% for oligocentric, and 89.5% for idiopathic castleman disease.
- Laboratory values such as hemoglobin and albumin differed significantly between idiopathic and unicentric castleman disease.
- Retrospective cohort analysis examined 217 patients classified by subtype and clinical presentation, revealing distinct outcomes.
- Findings support the updated classification of castleman disease, indicating the aggressive nature of idiopathic disease and treatment responses.
Cite This Study
Brent et al. (2025) studied this question.